Offer - Urjas Oil for just ₹ 1 X
Rosave F 5 Tablet (10) is a commercial drug that is prescribed in the form of Tablet. Rosave F 5 Tablet (10) also has some secondary and off-label uses. These are listed below.
The right dosage of Rosave F 5 Tablet (10) depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Rosave F 5 Tablet (10) include Nausea or vomiting, Headache, Constipation. Besides the aforementioned side effects, there are other adverse effects of Rosave F 5 Tablet (10) as well, which are listed below. These side effects of Rosave F 5 Tablet (10) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Rosave F 5 Tablet (10)'s effect during pregnancy is Moderate and Moderate while nursing. In addition, Rosave F 5 Tablet (10)'s effects on the liver, heart and kidney are discussed below in the Rosave F 5 Tablet (10) related warnings section.
Rosave F 5 Tablet (10) is contraindicated in people with pre-existing medical conditions like Diabetes as it can result in adverse effects.
Drug reaction of Rosave F 5 Tablet (10) with other medicines has been reported. See below for a complete list.
You should also be aware that Rosave F 5 Tablet (10) is not safe while driving, and is not addiction.
Rosave F 5 Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rosave F 5 Tablet (10) safe for pregnant women?
Pregnant women may experience moderate side effects from Rosave F. It is best to stop taking Rosave F immediately and inform your doctor if you notice any discomfort.
Is the use of Rosave F 5 Tablet (10) safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Rosave F. Immediately discontinue Rosave F if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Rosave F 5 Tablet (10) on the Kidneys?
Rosave F rarely affects the kidneys.
What is the effect of Rosave F 5 Tablet (10) on the Liver?
Rosave F is rarely harmful for the liver.
What is the effect of Rosave F 5 Tablet (10) on the Heart?
You may experience side effects on your heart after taking Rosave F. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Rosave F 5 Tablet (10) unless your doctor advises you to do so -
Is this Rosave F 5 Tablet (10) habit forming or addictive?
No, there is no any evidence that Rosave F 5 Tablet (10) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Rosave F 5 Tablet (10) can make you feel drowsy.
Is it safe?
Rosave F 5 Tablet (10) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Rosave F 5 Tablet (10) is not used to treat mental disorders.
Interaction between Food and Rosave F 5 Tablet (10)
Due to a lack of research, nothing can be said about the consequences of taking Rosave F 5 Tablet (10) together with food.
Interaction between Alcohol and Rosave F 5 Tablet (10)
Information about the interaction of Rosave F 5 Tablet (10) and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650